reninangiotensin
system
play
import
role
mainten
blood
pressur
homeostasi
angiotensinconvert
enzym
ace
convert
angiotensin
angiotensin
ii
angiotensin
ii
bind
angiotensin
ii
receptor
potent
vasoconstrictor
pathophysiolog
basi
ace
id
polymorph
lead
enhanc
activ
angiotensin
axi
therebi
possibl
contribut
circulatori
disturb
mutual
facilitatori
effect
may
presum
two
polymorph
examin
whether
synergist
effect
involv
evolut
differ
type
ischem
stroke
genet
clinic
data
consecut
patient
acut
develop
ischem
stroke
analyz
total
stroke
neuroimag
alterationfre
subject
serv
control
group
univari
logist
regress
statist
approach
use
ace
allel
combin
allel
yield
risk
ischem
stroke
howev
cooccurr
homozyg
ace
dd
least
one
allel
frequent
ischem
stroke
group
control
group
vs
p
ci
specif
subgroup
analysi
synergist
associ
even
stronger
smallvessel
ischem
stroke
ci
p
multivari
logist
regress
analysi
data
confirm
associ
adjust
ci
p
result
demonstr
ace
dd
neuromolecular
medicin
reninangiotensin
system
ra
play
import
role
mainten
blood
pressur
homeostasi
agachan
henderson
miller
angiotensinconvert
enzym
ace
convert
angiotensin
angiotensin
ii
angiotensin
ii
bind
angiotensin
ii
receptor
potent
vasoconstrictor
stimul
cardiac
growth
nichol
ace
display
polymorph
alter
function
ace
dd
polymorph
associ
elev
angiotensin
ii
level
demonstr
play
import
role
develop
ischem
stroke
leukoaraiosi
szolnoki
szolnoki
szolnoki
polymorph
lead
enhanc
respons
suggest
mild
suscept
factor
ischem
stroke
rubattu
brenner
polymorph
associ
enhanc
activ
angiotensin
axi
postul
clinic
level
synergist
effect
regard
evolut
ischem
stroke
also
analyz
extent
differ
subtyp
ischem
stroke
relat
genegen
interact
data
consecut
patient
acut
develop
ischem
stroke
never
suffer
previou
stroke
event
analyz
subject
admit
depart
neurolog
neurophysiolog
januari
examin
internist
local
emerg
unit
famili
physician
home
subject
underw
detail
clinic
scrutini
includ
medic
histori
famili
histori
evalu
vascular
risk
factor
gener
physic
neurolog
examin
urin
analysi
extens
laboratori
examin
electrocardiographi
extracrani
transcrani
doppler
sonographi
brainsuppli
arteri
transthorac
andor
transoesophag
echocardiographi
appropri
magnet
reson
imag
mri
examin
within
onset
symptom
scan
read
experienc
investig
without
knowledg
clinic
laboratori
data
patient
enrol
immedi
clinic
neurolog
mri
examin
subject
mri
could
record
examin
clinic
paramet
risk
factor
could
obtain
certainti
consequ
technic
caus
death
exclud
studi
group
patient
atrial
fibril
cardioembol
sourc
also
exclud
order
make
studi
group
homogen
follow
evalu
clinic
radiolog
featur
patient
enrol
one
three
subgroup
group
correspond
largevessel
infarct
cortic
cerebellar
lesion
andor
brainstem
infarct
subcort
hemispher
infarct
cm
diamet
mri
cerebr
cortic
impair
brainstem
cerebellar
dysfunct
group
correspond
smallvessel
occlus
one
subcort
hemispher
brainstem
infarct
diamet
less
cm
mri
one
featur
tradit
clinic
lacunar
syndrom
without
cerebr
cortic
dysfunct
group
correspond
mix
vascular
patholog
one
lacunar
largevessel
infarct
mri
lacunar
syndrom
corticalcerebellarbrainstem
dysfunct
classif
base
clinic
radiolog
featur
consid
exact
quantifi
method
regard
requir
subgroup
reflect
main
welldefin
vascular
patholog
overlap
may
possibl
affect
examin
mutat
polymorph
associ
develop
smallvessel
ischem
stroke
mutual
facilitatori
interplay
genet
interact
might
contribut
alter
function
network
reninangiotensin
system
vascular
disord
doi
index
entri
ace
id
polymorph
angiotensin
network
receptor
stroke
control
group
stroke
neuroimag
alterationfre
caucasian
hungarian
subject
examin
control
randomli
select
use
sexmatch
techniqu
gener
practic
regist
local
stroke
case
requir
neg
brain
mri
comput
tomographi
ct
find
order
avoid
silent
brain
infarct
healthi
believ
free
cerebrovascular
diseas
subject
previou
clinic
data
suggest
cerebrovascular
cardiovascular
event
transient
schemic
attack
angina
pectori
exclud
control
group
control
patient
gave
inform
consent
clinic
workup
dna
analysi
studi
approv
local
ethic
committe
smoke
drink
habit
presenc
hypertens
diabet
mellitu
record
group
serum
cholesterol
level
serum
triglycerid
level
platelet
count
hematocrit
also
measur
analyz
import
clinic
paramet
hypertens
diagnos
blood
pressur
repeatedli
exceed
mmhg
systol
andor
mmhg
diastol
patient
take
antihypertens
medic
diabet
mellitu
diagnos
glucos
level
least
mm
fast
state
andor
least
mm
h
meal
g
oral
glucos
load
accord
world
health
organ
criteria
ischem
heart
diseas
diagnos
histori
angina
pectori
acut
myocardi
infarct
present
electrocardiogram
evid
coronari
heart
diseas
patient
classifi
smoker
ever
smoke
five
cigarett
per
day
least
year
patient
consid
moder
heavi
drinker
drank
g
alcohol
per
day
bodi
mass
index
calcul
weight
kilogram
divid
squar
height
meter
genom
dna
extract
peripher
blood
anticoagul
edta
desalt
method
miller
blood
sampl
store
dna
isol
genbank
access
nt
genotyp
new
primer
set
construct
forward
primer
aaaagccaaatcccactcaa
revers
primer
pcr
perform
mj
research
thermal
cycler
reaction
volum
contain
dna
ng
primer
reaction
buffer
mm
trishcl
ph
contain
mm
kcl
mm
mgcl
dntp
two
unit
taq
polymeras
polymeras
chain
reaction
pcr
condit
follow
initi
denatur
follow
cycl
denatur
anneal
extens
pcr
product
digest
u
dde
new
england
biolab
kvalitex
scientif
technolog
trade
ltd
budapest
hungari
overnight
restrict
fragment
separ
electrophoresi
agaros
gel
contain
ethidium
bromid
visual
ultraviolet
illumin
result
bp
fragment
wherea
allel
result
bp
fragment
ace
polymorph
examin
pcr
method
develop
order
decreas
examin
time
provid
better
detect
heterozygot
somogyvari
method
consist
fluoresc
probe
melt
point
analysi
perform
fluoresc
label
oligonucleotid
hybrid
probe
instrument
roch
diagnost
roch
kft
budapest
hungari
genet
examin
carri
without
knowledg
result
clinic
workup
clinic
data
express
mean
sd
appropri
differ
clinic
paramet
stroke
group
control
assess
use
test
mannwhitney
test
appropri
stroke
group
test
control
group
frequenc
differ
genotyp
combin
test
logist
regress
model
evolv
evalu
import
cooccurr
ace
allel
ischem
stroke
main
genotyp
categori
examin
homozyg
ace
dd
polymorph
score
homozyg
state
szolnoki
et
al
neuromolecular
medicin
volum
heterozyg
state
lack
given
allel
presenc
least
one
ace
allel
score
homozyg
heterozyg
state
lack
given
allel
or
confid
interv
ci
calcul
logist
regress
analys
perform
statist
packag
systat
chicago
window
consequ
great
number
statist
comparison
aros
chanc
statist
signific
associ
regist
ischem
stroke
given
combin
pair
genotyp
accid
without
valid
biolog
associ
order
decreas
possibl
randomli
divid
group
two
identicals
sampl
carri
statist
calcul
independ
consid
associ
ischem
stroke
occurr
given
genotyp
biolog
valid
associ
calcul
statist
signific
p
independ
sampl
data
shown
method
approach
could
resolv
statist
problem
stem
exploratori
multipl
test
clinic
data
list
tabl
allel
occur
significantli
frequent
stroke
subgroup
largevessel
smallvessel
mix
type
overal
control
tabl
ace
dd
genotyp
meant
minor
risk
smallvessel
ischem
stroke
adjust
ci
p
tabl
result
confirm
divid
stroke
group
data
shown
cooccurr
ace
allel
consist
signific
risk
ischem
stroke
tabl
synergist
effect
found
allel
homozyg
ace
dd
genotyp
smallvessel
stroke
subgroup
adjust
ci
p
mix
vascular
type
adjust
ci
p
overal
ischem
stroke
group
adjust
ci
p
tabl
synergist
effect
shown
earlier
confirm
divid
stroke
group
mix
vascular
type
stroke
group
data
shown
low
number
homozyg
genotyp
dosedepend
effect
could
evalu
statist
combin
ace
allel
acedd
genotyp
popul
reveal
direct
associ
polymorph
ischem
stroke
ace
dd
genotyp
independ
minor
risk
factor
smallvessel
infarct
low
signific
level
result
present
studi
would
need
confirm
howev
associ
consist
earlier
find
szolnoki
cooccurr
ace
allel
enhanc
risk
ischem
stroke
subtyp
compar
control
group
combin
homozyg
ace
dd
genotyp
least
one
allel
increas
risk
ischem
stroke
specif
subgroup
analysi
synergist
associ
even
stronger
smallvesselassoci
ischem
stroke
although
tendenc
increas
genotyp
combin
largevessel
pathologyassoci
cerebr
infarct
signific
interplay
observ
subtyp
similar
synergist
associ
describ
ischem
heart
diseas
fukazawa
exact
explan
addit
effect
pathophysiolog
basi
howev
szolnoki
et
al
neuromolecular
medicin
volum
unfavor
polymorph
result
enhanc
activ
angiotensin
axi
enhanc
activ
lead
endotheli
dysfunct
vasoregul
disturb
de
ciucei
watanab
local
vasoregul
cerebr
blood
flow
take
place
smallvessel
level
normal
endotheli
function
essenti
process
accordingli
endotheli
dysfunct
lead
primarili
smallvessel
circulatori
disturb
associ
explain
synergist
interact
observ
led
smallvessel
infarct
presenc
ace
dd
genotyp
produc
elev
ace
level
therebi
yield
increas
level
angiotensin
ii
malik
data
show
allel
associ
increas
angiotensin
ii
respons
van
geel
jone
elev
level
angiotensin
ii
enhanc
respons
target
might
compris
molecular
basi
synergist
effect
seen
clinic
level
interplay
might
practic
implic
everyday
clinic
practic
increas
attent
recent
paid
primari
stroke
prevent
center
endotheli
protect
laros
modern
antihypertens
drug
ace
inhibitor
blocker
protect
endotheli
dysfunct
also
lower
blood
pressur
de
gennaro
higashi
saavedra
schmieder
zhou
pathophysiolog
basi
might
directli
counterbal
unfavor
effect
ace
dd
polymorph
de
gennaro
p
b
p
c
p
adjust
or
allel
clinic
risk
factor
logist
regress
model
adjust
differ
bodi
mass
index
serum
cholesterol
serum
triglycerid
diabet
mellitu
smoke
drink
habit
ischem
heart
diseas
higashi
saavedra
schmieder
zhou
identif
popul
higher
risk
ischem
stroke
consequ
combin
ace
dd
polymorph
may
help
select
patient
ace
inhibitor
andor
blocker
either
alon
combin
chosen
specif
prevent
tool
ischem
stroke
endotheli
dysfunct
associ
riski
haplotyp
ra
drug
respons
necessit
studi
